These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Author: Henry SA.
    Journal: Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331.
    Abstract:
    Response to aztreonam (1-2 g administered intravenously three or four times daily) was evaluated in a multiclinic study of 113 patients with intraabdominal infections due to gram-negative aerobic organisms. Appropriate therapy with an antibiotic (usually clindamycin) active against gram-positive and/or anaerobic organisms was administered concomitantly for mixed-pathogen infections. A favorable clinical response and microbiologic cure occurred in 90% of the patients treated. All of the 13 patients with infections due to Pseudomonas aeruginosa responded clinically, and 11 of the 13 patients experienced microbiologic cure. In a comparative study, 59 patients were treated with aztreonam and 56 were treated with tobramycin (3-5 mg/kg per day); 95% of the patients in the aztreonam group and 81% of those in the tobramycin group experienced microbiologic cure.
    [Abstract] [Full Text] [Related] [New Search]